Bomedemstat shows promise for Long-Term control of rare blood cancers
NCT ID NCT05223920
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 30 times
Summary
This study looked at the long-term safety and effectiveness of the drug bomedemstat in 81 people with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Participants had already taken bomedemstat in earlier studies and continued treatment to see how well it controlled their disease over time. The main goals were to track side effects, changes in spleen size, and platelet counts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY MYELOFIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedaliera SS. Antonio
Alessandria, 15121, Italy
-
Azienda Ospedaliero Universitaria di Bologna
Pavia, 27100, Italy
-
Azienda Ospedaliero-Universitaria Careggi - S.O.D. Ematologia (CRIMM)
Florence, 50134, Italy
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Fred Hutchinson Cancer Center
Seattle, Washington, 98109, United States
-
Gold Coast Hospital and Health Service
Southport, Queensland, 4215, Australia
-
Guy's and Saint Thomas' NHS Foundation Trus
London, SE1 9RT, United Kingdom
-
Middlemore Clinical Trials
Papatoetoe, Aukland, 2025, New Zealand
-
Ospedale di Circolo-a Fondazione Macchi
Varese, VA, 2100, Italy
-
Queen Mary Hospital
Hong Kong, Hong Kong
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
-
Royal North Shore Hospital
Saint Leonards, New South Wales, 2065, Australia
-
Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050, Australia
-
UMPC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
Universittsklinikum Essen
Essen, 45147, Germany
-
University College London Hospitals NHS Foundation Trust
London, NW1 12G, United Kingdom
-
University of Miami Leonard M. Miller
Miami, Florida, 33136, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
Waitemata District Health Board
Takapuna, Aukland, 0622, New Zealand
Conditions
Explore the condition pages connected to this study.